{"id":324515,"date":"2022-11-10T11:40:22","date_gmt":"2022-11-10T16:40:22","guid":{"rendered":"https:\/\/www.sgtreport.com\/?p=324515"},"modified":"2022-11-09T22:48:23","modified_gmt":"2022-11-10T03:48:23","slug":"pfizer-works-to-fast-track-more-vaccines-for-pregnant-moms-despite-mounting-evidence-rushed-covid-shots-harmed-babies","status":"publish","type":"post","link":"https:\/\/www.sgtreport.com\/2022\/11\/pfizer-works-to-fast-track-more-vaccines-for-pregnant-moms-despite-mounting-evidence-rushed-covid-shots-harmed-babies\/","title":{"rendered":"Pfizer Works to Fast-Track More Vaccines for Pregnant Moms, Despite Mounting Evidence Rushed COVID Shots Harmed Babies"},"content":{"rendered":"

from Childrens Health Defense<\/a>:<\/em><\/p>\n

\"\"<\/p>\n

The FDA, meanwhile, has been busy handing out \u201cBreakthrough Therapy<\/a>\u201d designations to Pfizer as if they were papal dispensations, signaling a regulatory willingness to\u00a0speed up approval<\/a>\u00a0not only for\u00a0Pfizer\u2019s RSV vaccine<\/a>\u00a0but also for a\u00a0maternal Group B Streptococcus<\/a>\u00a0(GBS) vaccine the company is developing.<\/p>\n

To this expedient end, the FDA allowed Pfizer to \u201cstop the [RSV] study short<\/a>,\u201d halting\u00a0enrollment at about 7,400<\/a>\u00a0participants \u2014 though the trial was supposed to involve\u00a010,000 pregnant women<\/a>.<\/p>\n

TRUTH LIVES on at\u00a0https:\/\/sgtreport.tv\/<\/a><\/p>\n

Researchers<\/a>\u00a0devoted to\u00a0vaccine orthodoxy<\/a>\u00a0pay lip service to the need for an extra-high evidentiary bar for pregnancy vaccines \u2014 stating that such vaccines should not only prove they reduce illness, with minimal\u00a0reactogenicity<\/a>\u00a0in the woman, the fetus and the neonate, but should also \u201cdemonstrate safety<\/a>\u00a0or lack of evidence of harm.\u201d<\/p>\n

However, those turn out to be empty words.<\/p>\n

In fact, the influenza and Tdap (tetanus-diphtheria-acellular pertussis) vaccines that public health agencies have long recommended for pregnant women never underwent any clinical trial safety testing in that population, and the\u00a0FDA never licensed<\/a>\u00a0those vaccines specifically for pregnant women.<\/p>\n

Moreover,\u00a0flu shots<\/a>\u00a0and Tdap shots have never even resulted in\u00a0any statistically significant reduction<\/a>\u00a0in the outcomes they are supposed to address.<\/p>\n

With the advent of Emergency Use Authorization COVID-19 vaccines, the FDA, Pfizer and other manufacturers barely made any pretense of\u00a0assessing maternal safety<\/a>, and likely \u201ccolluded together to conceal damaging data\u201d about\u00a0high rates of fetal death<\/a>.<\/p>\n

Other researchers, however \u2014 and even vaccine insiders \u2014 began to speak out in 2021.<\/p>\n

For example, Canadian researchers writing in late 2021 worried that many of the systemic reactions commonly reported after COVID-19 vaccination might be \u201csufficient to\u00a0affect fetal\/neonatal development<\/a>.\u201d<\/p>\n

Those authors included vaccinologist Byram Bridle, Ph.D., who earlier in 2021 characterized the COVID-19 vaccines\u2019 disturbing\u00a0biodistribution and accumulation in vital organs<\/a>\u00a0as \u201ca big mistake,\u201d and neurology professor Dr. Steven Pelech, who expressed repeated concerns about myocarditis and the\u00a0vaccines\u2019 risks to young people<\/a>.<\/p>\n

Now, as horrified pregnant women who took the COVID-19 jabs experience\u00a0skyrocketing miscarriages<\/a>, stillbirths and fetal malformations, they are wondering why regulators issued no warnings.<\/p>\n

But as Pfizer\u2019s exuberant RSV press release and the FDA\u2019s complacent endorsement of clinical trial shortcuts suggest, vaccine makers and regulators not only intend to ignore or bulldoze even the most outsized safety signals but are clearly positioning themselves to go after pregnant women in an even bigger way.<\/p>\n

Read More @ ChildrensHealthDefense.org<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

from Childrens Health Defense: The FDA, meanwhile, has been busy handing out \u201cBreakthrough Therapy\u201d designations to Pfizer as if they were papal dispensations, signaling a regulatory willingness to\u00a0speed up approval\u00a0not only for\u00a0Pfizer\u2019s RSV vaccine\u00a0but also for a\u00a0maternal Group B Streptococcus\u00a0(GBS) vaccine the company is developing. To this expedient end, the FDA allowed Pfizer to \u201cstop […]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[141910,141909],"_links":{"self":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/posts\/324515"}],"collection":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/comments?post=324515"}],"version-history":[{"count":0,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/posts\/324515\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/media?parent=324515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/categories?post=324515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/tags?post=324515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}